×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Gollob Jared

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerJul 15, 2024Option Exercise$2.0816,45534,226112,195Jul 16, 2024, 06:00 PM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerJul 15, 2024Sale$45.1516,455742,92595,740Jul 16, 2024, 06:00 PM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerJul 16, 2024Option Exercise$2.0823,14548,142118,885Jul 16, 2024, 06:00 PM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerJul 16, 2024Sale$45.8123,1451,060,218105,604Jul 16, 2024, 06:00 PM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerMar 04, 2024Sale$41.863,344139,96797,062Mar 04, 2024, 06:21 PM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerFeb 27, 2024Option Exercise$2.0840083275,109Feb 29, 2024, 04:34 PM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerFeb 27, 2024Sale$45.0040018,00074,709Feb 29, 2024, 04:34 PM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerFeb 09, 2024Option Exercise$2.0846,13795,965120,846Feb 09, 2024, 07:47 PM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerFeb 09, 2024Sale$35.5046,1371,638,07282,107Feb 09, 2024, 07:47 PM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerMay 04, 2022Option Exercise$1.6920,00033,74057,257May 04, 2022, 09:02 AM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerNov 01, 2021Option Exercise$1.4524,60735,78367,154Nov 02, 2021, 06:45 PM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerNov 01, 2021Sale$61.7842,4972,625,59559,767Nov 02, 2021, 06:45 PM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerNov 02, 2021Option Exercise$2.0814,99631,19239,653Nov 02, 2021, 06:45 PM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerNov 02, 2021Sale$63.2214,996948,06331,139Nov 02, 2021, 06:45 PM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerMar 15, 2021Sale$60.1710,305620,05242,547Mar 15, 2021, 09:12 PM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerMar 11, 2021Option Exercise$1.312,2002,88249,747Mar 15, 2021, 09:12 PM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerMar 11, 2021Sale$60.054,695281,93945,052Mar 15, 2021, 09:12 PM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerMar 15, 2021Option Exercise$1.317,80010,21852,852Mar 15, 2021, 09:12 PM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerFeb 23, 2021Sale$49.6519,285957,55456,222Feb 24, 2021, 06:44 PM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerFeb 24, 2021Sale$50.918,675441,67147,547Feb 24, 2021, 06:44 PM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerFeb 22, 2021Sale$52.639,104479,13075,507Feb 24, 2021, 06:44 PM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerFeb 17, 2021Sale$58.397,550440,83699,997Feb 19, 2021, 07:27 PM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerFeb 18, 2021Sale$55.946,499363,54093,498Feb 19, 2021, 07:27 PM
KYMRKymera Therapeutics, Inc.Gollob JaredChief Medical OfficerFeb 19, 2021Sale$55.098,887489,55984,611Feb 19, 2021, 07:27 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe